Diversity and relationships of cocirculating modern human rotaviruses revealed using large-scale comparative genomics

Journal of Virology

Volumn 86, Issue 17, 2012, Pages 9148-9162

  McDonald, Sarah M ^a,b   McKell, Allison O ^a,b   Rippinger, Christine M ^c   McAllen, John K ^d   Akopov, Asmik ^d   Kirkness, Ewen F ^d   Payne, Daniel C ^e   Edwards, Kathryn M ^f   Chappell, James D ^f   Patton, John T ^c  

^a VIRGINIA TECH CARILION SCHOOL OF MEDICINE   (United States)

^b VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d J CRAIG VENTER INSTITUTE   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTRUCTURAL PROTEIN 1; NONSTRUCTURAL PROTEIN 5; NONSTRUCTURAL PROTEIN 6; PROTEIN VP1; PROTEIN VP3; PROTEIN VP4; PROTEIN VP6; PROTEIN VP7; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ALLELE; ARTICLE; CHILD; CLADISTICS; COMPARATIVE STUDY; CONTROLLED STUDY; DIARRHEA; GENETIC IDENTIFICATION; GENETIC REASSORTMENT; GENETIC VARIABILITY; GENOME ANALYSIS; GENOTYPE; GEOGRAPHICAL VARIATION (SPECIES); HUMAN; HUMAN ROTAVIRUS; MICROBIAL DIVERSITY; NONHUMAN; NSP1 GENE; NSP5 GENE; NSP6 GENE; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; PRIORITY JOURNAL; PROTEIN DOMAIN; SEASONAL VARIATION; SEQUENCE ANALYSIS; UNINDEXED SEQUENCE; UNITED STATES; VIRAL GASTROENTERITIS; VIRUS GENE; VIRUS GENOME; VIRUS ISOLATION; VIRUS NEUTRALIZATION; VIRUS STRAIN; VOMITING; VP1 GENE; VP3 GENE; VP6 GENE;

CHILD; CHILD, PRESCHOOL; DIARRHEA; FEMALE; GASTROENTERITIS; GENETIC VARIATION; GENOME, VIRAL; GENOMICS; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PHYLOGENY; ROTAVIRUS; VIRAL PROTEINS;

RNA VIRUSES; ROTAVIRUS; ROTAVIRUS A;

EID: 84866148770     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01105-12     Document Type: Article

References (56)

1. Aoki ST, et al. 2009. Structure of rotavirus outer-layer protein VP7 bound with a neutralizing Fab. Science 324:1444-1447.
2. Armah GE, et al. 2010. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet 376:606-614.
3. Benati FJ, Maranhao AG, Lima RS, da Silva RC, Santos N. 2010. Multiple-gene characterization of rotavirus strains: evidence of genetic linkage among the VP7-, VP4-, VP6-, and NSP4-encoding genes. J. Med. Virol. 82:1797-1802.
4. Blanchard H, Yu X, Coulson BS, von Itzstein M. 2007. Insight into host cell carbohydrate-recognition by human and porcine rotavirus from crystal structures of the virion spike associated carbohydrate-binding domain (VP8*). J. Mol. Biol. 367:1215-1226.
5. Carvalho-Costa FA, et al. 2011. Laboratory-based rotavirus surveillance during the introduction of a vaccination program, Brazil, 2005-2009. Pediatr. Infect. Dis. J. 30:S35-S41.
6. Chaimongkol N, et al. 2012. Genotypic linkages of gene segments of rotaviruses circulating in pediatric patients with acute gastroenteritis in Thailand. Infect. Genet. Evol. 12:1381-1391.
7. Clark HF, Lawley D, DiStefano D, Matthijnssens J, Dinubile MJ. 2011. Distribution of rotavirus genotypes causing nosocomial and communityacquired acute gastroenteritis at the Children's Hospital of Philadelphia in the new rotavirus vaccine era. Hum. Vaccine 7:1118-1123.
8. Cortese MM, Parashar UD. 2009. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 58:1-25.
9. Desselberger U, Huppertz HI. 2011. Immune responses to rotavirus infection and vaccination and associated correlates of protection. J. Infect. Dis. 203:188-195.
10. Dormitzer PR, Sun ZY, Wagner G, Harrison SC. 2002. The rhesus rotavirus VP4 sialic acid binding domain has a galectin fold with a novel carbohydrate binding site. EMBO J. 21:885-897.
11. Estes MK, Kapikian AZ. 2007. Rotaviruses and their replication, p 1917-1974. In Fields virology (5th ed), Knipe DM, et al, Lippincott Williams & Wilkins, Philadelphia, PA.
12. Gentsch JR, et al. 2009. G and P types of circulating rotavirus strains in the United States during 1996-2005: nine years of prevaccine data. J. Infect. Dis. 200(Suppl. 1):S99-S105.
13. Gentsch JR, Parashar UD, Glass RI. 2009. Impact of rotavirus vaccination: the importance of monitoring strains. Future Microbiol. 4:1231-1234.
14. Gouvea V, Brantly M. 1995. Is rotavirus a population of reassortants? Trends Microbiol. 3:159-162.
15. Gray J. 2011. Rotavirus vaccines: safety, efficacy and public health impact. J. Intern. Med. 270:206-214.
16. Heiman EM, et al. 2008. Group A human rotavirus genomics: evidence that gene constellations are influenced by viral protein interactions. J. Virol. 82:11106-11116.
17. Hull JJ, et al. 2011. United States rotavirus strain surveillance from 2005 to 2008: genotype prevalence before and after vaccine introduction. Pediatr. Infect. Dis. J. 30:S42-S47.
18. Iturriza-Gomara M, et al. 2003. Evidence for genetic linkage between the gene segments encoding NSP4 and VP6 proteins in common and reassortant human rotavirus strains. J. Clin. Microbiol. 41:3566-3573.
19. Iturriza-Gomara M, et al. 2011. Rotavirus genotypes co-circulating in Europe between 2006 and 2009 as determined by EuroRotaNet, a pan-European collaborative strain surveillance network. Epidemiol. Infect. 139:895-909.
20. Iturriza-Gomara M, et al. 2009. Rotavirus surveillance in europe, 2005-2008: web-enabled reporting and real-time analysis of genotyping and epidemiological data. J. Infect. Dis. 200(Suppl. 1):S215-S221.
21. Jayaram H, Taraporewala Z, Patton JT, Prasad BV. 2002. Rotavirus protein involved in genome replication and packaging exhibits a HIT-like fold. Nature 417:311-315.
22. Jere KC, et al. 2011. Whole genome analyses of African G2, G8, G9, and G12 rotavirus strains using sequence-independent amplification and 454(R) pyrosequencing. J. Med. Virol. 83:2018-2042.
23. Jiang X, et al. 2006. Cryoelectron microscopy structures of rotavirus NSP2-NSP5 and NSP2-RNA complexes: implications for genome replication. J. Virol. 80:10829-10835.
24. Kirkwood CD, Boniface K, Bishop RF, Barnes GL. 2010. Australian Rotavirus Surveillance Program: annual report, 2009/2010. Commun. Dis. Intell. 34:427-434.
25. Madhi SA, et al. 2010. Effect of human rotavirus vaccine on severe diarrhea in African infants. N. Engl. J. Med. 362:289-298.
26. Maes P, Matthijnssens J, Rahman M, Van Ranst M. 2009. RotaC: a web-based tool for the complete genome classification of group A rotaviruses. BMC Microbiol. 9:238. doi:10.1186/1471-2180-9-238.
27. Malek MA, et al. 2006. Diarrhea- and rotavirus-associated hospitalizations among children less than 5 years of age: United States, 1997 and 2000. Pediatrics 117:1887-1892.
28. Matthijnssens J, et al. 2008. Full genome-based classification of rotaviruses reveals a common origin between human Wa-Like and porcine rotavirus strains and human DS-1-like and bovine rotavirus strains. J. Virol. 82:3204-3219.
29. Matthijnssens J, et al. 2011. Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Arch. Virol. 156:1397-1413.
30. Matthijnssens J, et al. 2010. Phylodynamic analyses of rotavirus genotypes G9 and G12 underscore their potential for swift global spread. Mol. Biol. Evol. 27:2431-2436.
31. Matthijnssens J, et al. 2010. Molecular and biological characterization of the 5 human-bovine rotavirus (WC3)-based reassortant strains of the pentavalent rotavirus vaccine, RotaTeq. Virology 403:111-127.
32. McDonald SM, Davis K, McAllen JK, Spiro DJ, Patton JT. 2011. Intra-genotypic diversity of archival G4P[8] human rotaviruses from Washington, DC. Infect. Genet. Evol. 11:1586-1594.
33. McDonald SM, et al. 2009. Evolutionary dynamics of human rotaviruses: balancing reassortment with preferred genome constellations. PLoS Pathog. 5:e1000634. doi:10.1371/journal.ppat.1000634.
34. McDonald SM, Patton JT. 2011. Assortment and packaging of the segmented rotavirus genome. Trends Microbiol. 19:136-144.
35. Nakagomi O, Nakagomi T, Akatani K, Ikegami N. 1989. Identification of rotavirus genogroups by RNA-RNA hybridization. Mol. Cell. Probes 3:251-261.
36. O'Ryan M, Linhares AC. 2009. Update on Rotarix: an oral human rotavirus vaccine. Expert Rev. Vaccines 8:1627-1641.
37. Parashar UD, Gibson CJ, Bresse JS, Glass RI. 2006. Rotavirus and severe childhood diarrhea. Emerg. Infect. Dis. 12:304-306.
38. Patton JT, Silvestri LS, Tortorici MA, Vasquez-Del Carpio R, Taraporewala ZF. 2006. Rotavirus genome replication and morphogenesis: role of the viroplasm. Curr. Top. Microbiol. Immunol. 309:169-187.
39. Payne DC, et al. 2008. Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States. Pediatrics 122:1235-1243.
40. Payne DC, et al. 2011. Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US Counties, 2006-2009. Clin. Infect. Dis. 53:245-253.
41. Payne DC, et al. 2009. Secular variation in United States rotavirus disease rates and serotypes: implications for assessing the rotavirus vaccination program. Pediatr. Infect. Dis. J. 28:948-953.
42. Pettersen EF, et al. 2004. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 25:1605-1612.
43. Phua KB, et al. 2009. Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: randomised, double-blind, controlled study. Vaccine 27:5936-5941.
44. Pitzer VE, et al. 2011. Modeling rotavirus strain dynamics in developed countries to understand the potential impact of vaccination on genotype distributions. Proc. Natl. Acad. Sci. U. S. A. 108:19353-19358.
45. Posada D, Buckley TR. 2004. Model selection and model averaging in phylogenetics: advantages of Akaike information criterion and Bayesian approaches over likelihood ratio tests. Syst. Biol. 53:793-808.
46. Potgieter AC, et al. 2009. Improved strategies for sequence-independent amplification and sequencing of viral double-stranded RNA genomes. J. Gen. Virol. 90:1423-1432.
47. Rahman M, et al. 2007. Evolutionary history and global spread of the emerging g12 human rotaviruses. J. Virol. 81:2382-2390.
48. Ramani S, et al. 2007. Geographic information systems and genotyping in identification of rotavirus G12 infections in residents of an urban slum with subsequent detection in hospitalized children: emergence of G12 genotype in south India. J. Clin. Microbiol. 45:432-437.
49. Takahashi K, Nei M. 2000. Efficiencies of fast algorithms of phylogenetic inference under the criteria of maximum parsimony, minimum evolution, and maximum likelihood when a large number of sequences are used. Mol. Biol. Evol. 17:1251-1258.
50. Tate JE, et al. 2012. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect. Dis. 12:136-141.
51. Trask SD, Taraporewala ZF, Boehme KW, Dermody TS, Patton JT. 2010. Dual selection mechanisms drive efficient single-gene reverse genetics for rotavirus. Proc. Natl. Acad. Sci. U. S. A. 107:18652-18657.
52. Vesikari T, et al. 2007. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 370:1757-1763.
53. Ward RL, Bernstein DI. 2009. Rotarix: a rotavirus vaccine for the world. Clin. Infect. Dis. 48:222-228.
54. Widdowson MA, et al. 2007. Cost-effectiveness and potential impact of rotavirus vaccination in the United States. Pediatrics 119:684-697.
55. Zaman K, et al. 2010. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet 376:615-623.
56. Zeller M, et al. 2012. Genetic analyses reveal differences in the VP7 and VP4 antigenic epitopes between human rotaviruses circulating in Belgium and rotaviruses in Rotarix and RotaTeq. J. Clin. Microbiol. 50:966-976.